Place of electroconvulsive therapy among the somatic treatments in a university clinic psychiatric inpatients;Bir üniversite hastanesi yatakli psikiyatri servisinde uygulanan somatik tedaviler arasinda elektrokonvülzif tedavinin yeri

Klinik Psikofarmakoloji Bulteni

Volumn 13, Issue 2, 2003, Pages 65-71

  Yildiz, Ayşegül ^a,d   Gökmen, Necati ^b   Turgut, Kübra ^a   Yücel, Gökhun ^c   Tunca, Zeliha ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Mikrobiyoloji Anabilim Dali   (Turkey)

^c Cocuk Psikiyatrisi Anabilim Dali ^*  (Turkey)

^d NONE   (Turkey)

Author keywords

Electroconvulsive therapy; Psychopharmacology; Relapse

Indexed keywords

ARTICLE; ELECTROCONVULSIVE THERAPY; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH SERVICE; RELAPSE; TURKEY (REPUBLIC);

EID: 0038034031     PISSN: 10177833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Fink M. Convulsive therapy: a review of the first 55 years. J Aff Disorders 2001;63:1-15
2. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatry 1994;151:1657-1667
3. Babigion HM, Guttmacher LB. Epidemiological considerations in electroconvulsive therapy. Arch Gen Psychiatry 1984;41:246-253
4. Rosenbach ML, Hermann RC, Dorwart RA. Use of electroconvulsive therapy in the medicare population between 1987 and 1992. Psychiatry Serv 1997;48:1537-1542
5. Malla A. An Epiodemiological study of electroconvulsive therapy: rate and diagnosis. Can J Psychiatry 1986;31:824-830.
6. Smith WE, Richman A. Electroconvulsive therapy: a Canadian perspective. Can J Psychiatry 1984;29:693-699
7. Hirschfeld RMA. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry 1999;60:326-335
8. Gelenberg AJ, Chesen CL. How fast are antidepressant? J Clin Psychiatry 2000;61:712-721
9. Fink M. The decision to use ECT: for whom? when? Mod Probl Pharmacopsychiatry 1997;25:203-214
10. Glass RM. Electroconvulsive therapy: time to bring it out of the shadows. JAMA 2001;285:1346-1348
11. Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT. Br J Psychiatry 1998;172:44-48
12. Bailine SH, Rifkin A, Kayne E, Selzer JA, Vitalherne J, Blieka M, Pollack S. Comparision of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 2000;157:121-123
13. Krystal AD, Dean MD, Weiner RD, Tramontozzi LA 3rd, Connor KM, Lindahl VH, Massie RW. ECT stimulus intensity: are present ECT devices too limited? Am J Psychiatry 2000;157:963-967
14. Pluijms EM, Birkenhager TK, Huijbrechts IPAM, Moleman P. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affective Disorders 2002;69:93-99
15. Öztürkoǧlu M. Elektrokonvulsif tedavinin antidepresan etkinliǧi ve yan etkileri. Uzmanlik Tezi, Çukurova Üniversitesi Tip Fakültesi Psikiyatri Anabilim Dali, Adana: 1993
16. Shapira B, Gorfine M, Lener B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther 1995;11:80-85
17. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and contuniation pharmacotherapy on relapse following response to ECT in major depression. J Clin Psychopharmacol 1990;10:96-104.
18. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J. Contuniation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 2001;285:1299-1307
19. Abrams R. Relapse of depression after electroconvulsive therapy. JAMA 2001;285:3087
20. Gagne GG Jr, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long term antidepressants alone in depressed patients. Am J Psychiatry 2000;157:1960-1965
21. Sackeim HA. Continuation therapy following ECT: directions for future resarch. Psychopharmacol Bull 1994;30:501-521
22. Fox HA. Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT 2001;17:60-64
23. Hermann RC, Dorwart RA, Hoover CW, Brody J. Variation in ECT use in the United States. Am J Psychiatry 1995;152:869-875
24. Bland RC, Brintnell S. Electroconvulsive therapy in a major teaching hospital: diagnoses and indications. J ECT 1999;15:140-149
25. Kramer BA, Pi EH. A Survey of ECT use in Asia. Convuls Ther 1990;6:26-31
26. Andersson JE, Bolwig TG. Electroconvulsive therapy in Denmark in 1999: a nation-wide questionnaire study. Ugeskr Laeger 2002;164:3449-3452
27. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, American Psychiatric Association, Washington DC: 1994
28. Zeren T. Elektrokonvulsif Terapi: 12 yillik bir deǧerlendirme. Uzmanlik Tezi, Çukurova Üniversitesi Tip Fakültesi Psikiyatri Anabilim Dali, Adana: 2003
29. Cimilli C, Kaya N, Inal N, Sarsu S, Topkaya Ş, Tunçel E. ECT in bipolar disorder. Ephesus Days, Bipolar Disorders, Book of Abstracts. Izmir: 1998; 63
30. Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999;89:157-166
31. Lee KA, Masson N. Transcriptional regulation by CREB and its relatives. Biochim Biophys Acta 1993;1174:221-233
32. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999;46:1181-1191
33. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressants treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110
34. Hyman SE, Nestler EJ. Initiation and Adaptation: A paradigm for understanding psychotropic drug action. Am J Psychiatry 1996;153:151-162
35. Rosin DL, Melia K, Knorr AM, Nestler EJ, Roth RH, Duman RS. Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain. Neuropsychopharmacol 1995;12:113-121